ada guidelines dpp4 and glp-1 The Role of RAs in the Management of Type 2 Diabetes Cardiovascular Risk Prescribing pearls: A guide to

Bouter C, Henniges P, Franke TN, Irwin C, Sahlmann CO, Sichler ME, et al

doi: 10.1016/j.smrv.2016.02.001

Keep reading Published on: January 11, 2021 Expert Stroke Care at Wellstar No stroke is ever the same

Additionally, improved glycemic control with GLP-1 RAs in T2DM patients may reduce glycosuria, a process known as glycemic buffering, which reduces caloric loss through urine and offsets part of the energy deficit induced by treatment [43,44,45]

Spironolactone can also cause changes in the bloods pH, causing either acidosis (too much acid) or alkalosis (too little acid)

However, if you feel discomfort from constipation or bloating, you should talk to a doctor